2.97 USD
-0.04 (-1.33%)
Taking everything into account, CCLD scores 5 out of 10 in our fundamental rating. CCLD was compared to 35 industry peers in the Health Care Technology industry. CCLD has only an average score on both its financial health and profitability. CCLD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CCLD had positive earnings in the past year.
CCLD had a positive operating cash flow in the past year.
In the past 5 years CCLD always reported negative net income.
CCLD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.63%, CCLD belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
With an excellent Return On Equity value of 4.12%, CCLD belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
CCLD has a Return On Invested Capital of 13.98%. This is amongst the best in the industry. CCLD outperforms 97.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.63% | ||
| ROE | 4.12% | ||
| ROIC | 13.98% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CCLD has a Profit Margin of 2.08%. This is amongst the best in the industry. CCLD outperforms 82.86% of its industry peers.
Looking at the Operating Margin, with a value of 10.43%, CCLD belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
In the last couple of years the Operating Margin of CCLD has grown nicely.
CCLD's Gross Margin of 46.49% is on the low side compared to the rest of the industry. CCLD is outperformed by 71.43% of its industry peers.
CCLD's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.43% | ||
| PM (TTM) | 2.08% | ||
| GM | 46.49% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
CCLD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CCLD has been increased compared to 1 year ago.
The number of shares outstanding for CCLD has been increased compared to 5 years ago.
CCLD has a better debt/assets ratio than last year.
2.2 Solvency
CCLD has an Altman-Z score of 3.21. This indicates that CCLD is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.21, CCLD is doing good in the industry, outperforming 71.43% of the companies in the same industry.
CCLD has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
CCLD's Debt to FCF ratio of 0.38 is fine compared to the rest of the industry. CCLD outperforms 77.14% of its industry peers.
CCLD has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
CCLD has a Debt to Equity ratio of 0.12. This is comparable to the rest of the industry: CCLD outperforms 48.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.38 | ||
| Altman-Z | 3.21 |
ROIC/WACC1.4
WACC10.01%
2.3 Liquidity
CCLD has a Current Ratio of 1.26. This is a normal value and indicates that CCLD is financially healthy and should not expect problems in meeting its short term obligations.
CCLD has a worse Current ratio (1.26) than 71.43% of its industry peers.
CCLD has a Quick Ratio of 1.15. This is a normal value and indicates that CCLD is financially healthy and should not expect problems in meeting its short term obligations.
CCLD has a Quick ratio of 1.15. This is in the lower half of the industry: CCLD underperforms 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
CCLD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.27%, which is quite impressive.
CCLD shows a small growth in Revenue. In the last year, the Revenue has grown by 2.97%.
Measured over the past years, CCLD shows a quite strong growth in Revenue. The Revenue has been growing by 11.47% on average per year.
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%
3.2 Future
Based on estimates for the next years, CCLD will show a very strong growth in Earnings Per Share. The EPS will grow by 61.62% on average per year.
Based on estimates for the next years, CCLD will show a quite strong growth in Revenue. The Revenue will grow by 9.34% on average per year.
EPS Next Y145.9%
EPS Next 2Y61.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 74.25, CCLD can be considered very expensive at the moment.
68.57% of the companies in the same industry are more expensive than CCLD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CCLD to the average of the S&P500 Index (26.84), we can say CCLD is valued expensively.
Based on the Price/Forward Earnings ratio of 24.26, the valuation of CCLD can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CCLD is valued a bit cheaper than 71.43% of the companies in the same industry.
CCLD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.40, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 74.25 | ||
| Fwd PE | 24.26 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCLD indicates a rather cheap valuation: CCLD is cheaper than 97.14% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than CCLD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.96 | ||
| EV/EBITDA | 4.95 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CCLD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CCLD's earnings are expected to grow with 61.62% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y61.62%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCLD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:CCLD (12/30/2025, 12:17:26 PM)
2.97
-0.04 (-1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners14.42%
Ins Owner Change5.25%
Market Cap125.93M
Revenue(TTM)114.31M
Net Income(TTM)2.38M
Analysts80
Price Target5.74 (93.27%)
Short Float %1.27%
Short Ratio1.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)63.4%
Min EPS beat(2)30.72%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)6.7%
EPS beat(12)8
Avg EPS beat(12)0.7%
EPS beat(16)12
Avg EPS beat(16)12.54%
Revenue beat(2)1
Avg Revenue beat(2)2.58%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)6.44%
Revenue beat(4)2
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.44%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)3
Avg Revenue beat(16)-2.05%
PT rev (1m)-2.17%
PT rev (3m)18.42%
EPS NQ rev (1m)-12.5%
EPS NQ rev (3m)16.67%
EPS NY rev (1m)12.5%
EPS NY rev (3m)12.5%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)2.88%
Revenue NY rev (1m)1.54%
Revenue NY rev (3m)3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 74.25 | ||
| Fwd PE | 24.26 | ||
| P/S | 1.1 | ||
| P/FCF | 6.96 | ||
| P/OCF | 4.93 | ||
| P/B | 2.18 | ||
| P/tB | 20.52 | ||
| EV/EBITDA | 4.95 |
EPS(TTM)0.04
EY1.35%
EPS(NY)0.12
Fwd EY4.12%
FCF(TTM)0.43
FCFY14.37%
OCF(TTM)0.6
OCFY20.27%
SpS2.7
BVpS1.36
TBVpS0.14
PEG (NY)0.51
PEG (5Y)N/A
Graham Number1.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.63% | ||
| ROE | 4.12% | ||
| ROCE | 17.7% | ||
| ROIC | 13.98% | ||
| ROICexc | 14.93% | ||
| ROICexgc | 82.32% | ||
| OM | 10.43% | ||
| PM (TTM) | 2.08% | ||
| GM | 46.49% | ||
| FCFM | 15.84% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y52.71%
ROICexgc growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score6
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.38 | ||
| Debt/EBITDA | 0.26 | ||
| Cap/Depr | 51.55% | ||
| Cap/Sales | 6.5% | ||
| Interest Coverage | 118.08 | ||
| Cash Conversion | 96.95% | ||
| Profit Quality | 760.91% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 3.21 |
F-Score6
WACC10.01%
ROIC/WACC1.4
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y145.9%
EPS Next 2Y61.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.97%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%8.83%
Revenue Next Year6.69%
Revenue Next 2Y9.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y128.34%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year219.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y212.1%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y43.66%
OCF growth 3Y15.69%
OCF growth 5Y22.06%
CARECLOUD INC / CCLD FAQ
What is the fundamental rating for CCLD stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCLD.
Can you provide the valuation status for CARECLOUD INC?
ChartMill assigns a valuation rating of 6 / 10 to CARECLOUD INC (CCLD). This can be considered as Fairly Valued.
How profitable is CARECLOUD INC (CCLD) stock?
CARECLOUD INC (CCLD) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for CCLD stock?
The Price/Earnings (PE) ratio for CARECLOUD INC (CCLD) is 74.25 and the Price/Book (PB) ratio is 2.18.
What is the earnings growth outlook for CARECLOUD INC?
The Earnings per Share (EPS) of CARECLOUD INC (CCLD) is expected to grow by 145.9% in the next year.